
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.320 | 2.610 | 0.290 |
Stocks | 97.680 | 97.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.320 | 17.869 |
Price to Book | 3.035 | 3.669 |
Price to Sales | 5.188 | 5.420 |
Price to Cash Flow | 12.243 | 13.349 |
Dividend Yield | 0.725 | 0.510 |
5 Years Earnings Growth | 35.463 | 16.844 |
Number of long holdings: 51
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.88 | 504.77 | +0.37% | |
Alnylam | US02043Q1076 | 6.80 | 241.76 | +0.00% | |
Neurocrine | US64125C1099 | 6.44 | 110.75 | +1.61% | |
Guardant Health | US40131M1099 | 4.88 | 42.89 | +5.54% | |
AbbVie | US00287Y1091 | 4.82 | 211.77 | +0.10% | |
Gilead | US3755581036 | 4.21 | 111.44 | -1.69% | |
Amgen | US0311621009 | 3.79 | 313.71 | +0.34% | |
Moderna | US60770K1079 | 3.51 | 34.62 | +0.93% | |
Denali Therapeutics | US24823R1059 | 3.49 | 15.15 | +1.75% | |
Roivant Sciences Ltd Ordinary Shares | - | 3.12 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1300848345 | 6.18B | 0.11 | -0.60 | - | ||
LU1313519925 | 6.18B | 0.09 | -0.90 | 4.86 | ||
LU1323611266 | 3.83B | 4.34 | 0.23 | - | ||
LU1520716801 | 3.83B | 7.31 | 2.63 | - | ||
UBS luxEqSICAV USA Growth USD P Acc | 2.61B | 30.57 | 6.64 | 13.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review